CIK 0001580149 · Non-accelerated filer<br>Smaller reporting company
BIOVIE INC.
Sign in to watch- Ticker
- BIVI
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- NV
- Entity type
- operating
- EIN
- 462510769
- Phone
- 775-888-3162
- Business address
- 680 W NYE LANE, SUITE 201, CARSON CITY, NV, 89703
- Former names
- NANOANTIBIOTICS, INC.
Securities
- BIVI Common stock Nasdaq
- BIVIW Warrant Nasdaq
- 8-K Event Other events
- 424B5 Offering Prospectus
- S-1 Offering Registration Statement
- 8-K Event Shareholder vote results
- 10-Q Report Quarterly Report
- 8-K Event Other events
- 424B5 Offering Prospectus
- DEF 14A Proxy Proxy Statement
- 10-K Report Annual Report
- 8-K/A Event Regulation FD disclosure · Other events
- 8-K Event Regulation FD disclosure · Other events
- 8-K Event Material agreement
- 424B5 Offering Prospectus
- 4 Grant or award Director acquired 16,380,096 shares (grant or award)
- SC 13D/A Stake Beneficial Ownership Report
- 4 Grant or award Director acquired 3,636,364 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- D Other Notice of Sales of Unregistered Securities
- DEF 14C Other DEF 14C
- 8-K/A Event Material agreement · Unregistered share sale
Page 12 of 26 · 511 filings